Arquivamento definitivo - Art. 33 da LPI
#11.1.1
01/06/2026
RPI 2870
Application data
Number
112024007316Type
Filing
Publication
PCT
US2022078157 The application was abandoned: examination was not requested within the 36 months following the 10/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.
Applicants
AMGEN INC.
US
CYTOMX THERAPEUTICS, INC.
US
Inventors
E. F. (pessoa física)
US
J. S. (pessoa física)
US
L. B. (pessoa física)
US
M. P. (pessoa física)
US
R. B. (pessoa física)
US
S. M. (pessoa física)
US
W. K. (pessoa física)
US
IPC Classification
Priority claims
US
63/256.410 · 10/15/2021
US
63/370.895 · 08/09/2022
Abstract
COMPLEXO POLIPEPTÍDICO ATIVÁVEL.A presente divulgação refere-se a complexos polipeptídicos biespecíficos heteromultiméricos (HBPCs) anti-EGFR, anti-CD3 ativável, e métodos de produção e uso dos mesmos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
01/06/2026
RPI 2870
#11.1
10/21/2025
RPI 2859
#1.3
07/23/2024
RPI 2794
#1.1
04/24/2024
RPI 2781
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.